A Review of Photodynamic Therapy for Intraocular Tumors | OMICS International | Abstract
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

A Review of Photodynamic Therapy for Intraocular Tumors

Tsipursky MS1*, Churgin DS2, Conway MD3 and Peyman GA3

1Carle Physician Group and Carle Foundation Hospital, Urbana, Illinois

2University of Arizona College of Medicine, Phoenix, AZ, USA

3University of Arizona College of Medicine, Tucson, Arizona, USA

*Corresponding Author:
Tsipursky MS
Carle Physician Group and Carle Foundation Hospital
Urbana, Illinois
E-mail: [email protected]

Received date: June 21, 2011; Accepted date: July 19, 2011; Published date: Augutst 02, 2011

Citation: Tsipursky MS, Churgin DS, Conway MD, Peyman GA (2011) A Review of Photodynamic Therapy for Intraocular Tumors. J Anal Bioanal Tech S1:001. doi: 10.4172/2155-9872.S1-001

Copyright: © 2011 Tsipursky MS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Photodynamic therapy (PDT) has been used in ophthalmology for various vascular conditions affecting the retina and choroid since the late 1990’s. As of 2000, verteporfin (Visudyne; CIBA Vision Corp, Duluth, Ga) photosensitizer for ocular conditions was used in treatment of choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), pathologic myopia, and presumed ocular histoplasmosis syndrome